Navigation Links
men in Biological Technology

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

... of the prostate, affecting more than 20 million men in the U.S. alone. "We are very pleased to have ... (BPH) is one of the most common diseases of aging men - affecting more than 20 million men in the United States - but its etiology is far ...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

... of the prostate, affecting more than 20 million men in the U.S. alone. Sanofi-aventis U.S. LLC ... (BPH) is one of the most common diseases of aging men - affecting more than 20 million men in the United States - but its etiology is far ...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

... in combination with docetaxel and prednisone in men with castrate-resistant prostate cancer ... presentation reported data from a cohort of men with docetaxel-refractory prostate cancer who ... with docetaxel (D) and prednisone (P) in men with castrate resistant prostate cancer (CRPC). ...

Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer

... upregulation and peripheral immune responses in men enrolled in the trial. PROVENGE or placebo ... in APCs is maintained after boosting in men with androgen-dependent prostate cancer," said ... consistent with that observed in our studies of men with androgen-independent disease where the ...

PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

... 3 IMPACT study of PROVENGE(R) (sipuleucel-T) in men with advanced prostate cancer met its primary ... A deno C arcinoma T reatment) study enrolled men with metastatic androgen-independent prostate ... Dendreon's investigational product candidate for men with advanced prostate cancer and may represent ...

AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia

... of the prostate, affecting more than 20 million men in the U.S. alone. Under the terms of the ... to market which could provide millions of men with a novel treatment for BPH. Furthermore, this ... (BPH) is one of the most common diseases of aging men - affecting more than 20 ...

Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

... Memorial Sloan-Kettering Cancer Center. "These men have a limited life expectancy, and currently ... results and the large unmet medical need for men with castration-resistant prostate cancer, I am ... common cancer worldwide. More than 1 million men in the United States have prostate cancer. In ...

International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System

... cancer is the most common cancer in American men other than skin cancers. One in six men will develop prostate cancer in their lifetime, and in 2007 over 200,000 men were newly diagnosed with the disease. ...

Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study

... cancer is the most common cancer in American men other than skin cancers. One in six men will develop prostate cancer in their lifetime, and in 2007 over 200,000 men were newly diagnosed with the disease. ...

Exposure to Agent Orange linked to prostate cancer in Vietnam veterans

... form of cancer by studying a large population of men in their 60s and the prostate-specific antigen ... that were either too small or conducted on men who were too young, patients in the current study ... and 2006, the study revealed that twice as many men exposed to Agent Orange were identified with ...

Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries

... cancer is the most common cancer in American men other than skin cancers. One in six men will develop prostate cancer in their lifetime, ... cancer grows relatively slowly and 7 out of 10 men are diagnosed in the early stages of the disease ...

Dendreon Reports Third Quarter 2008 Financial Results

... immunotherapy PROVENGE(R) (sipuleucel-T) in men with metastatic androgen-independent ... * Initiated a Phase 2 trial of PROVENGE in men with localized prostate cancer who are ... surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and ...

AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia

... and convenient treatment for the millions of men with BPH." The study, titled, "Cetrorelix ... (BPH) is one of the most common diseases of aging men - affecting more than 20 million men in the United States - but its etiology is far ...

Exposure to Agent Orange linked to prostate cancer in Vietnam veterans

... form of cancer by studying a large population of men in their 60s and the prostate-specific antigen ... that were either too small or conducted on men who were too young, patients in the current study ... and 2006, the study revealed that twice as many men exposed to Agent Orange were identified with ...

Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers'

... N.J., Sept. 22 /PRNewswire/ -- A new survey of men and women age 40 and older in the United States ... were to be applied to the total populations of men over 40 and women over 50 it could mean that as ... heart disease. ** Using population numbers for men over 40 and women over 50 from the U.S. census ...

Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment

... HUNTINGTON BEACH, Calif., Sept. 5 /PRNewswire/ -- men in the Los Angeles area who suffer from the ... ) "Too many men suffer with the symptoms of frequent or ... offered by the LIFE(TM) procedure means that men can now easily treat what is one of the most ...

Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon

... EAST LONGMEADOW, Mass., Sept. 5 /PRNewswire/ -- men living in Western Oregon who suffer from the ... ) "Too many men suffer with the symptoms of frequent or ... Chief Operating Officer for biolitec. "Often men are reluctant to seek treatment, thinking the ...

Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer

... common cancer worldwide. More than one million men in the United States have prostate cancer, with ... to be diagnosed in 2008, and approximately 28,660 men expected to die this year from the disease. Currently there are limited treatment options for men with advanced, metastatic prostate cancer. ...

FDA Approves GlaxoSmithKline's AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate

... prostate, a disease that affects half of all men over 50 years old. The new indication reflects ... one of the largest clinical trials to date of men with enlarged prostate. The CombAT study is the ... double-blind and parallel-group study. men [aged greater than or equal to 50 years with a ...

Growing Generations Announces Surrogacy Program for Men with HIV

... provides surrogacy and egg donation services to men with HIV and allows them to use their own sperm ... The company already has five cases of men with HIV working with egg donors and surrogates, ... and preparation process for the sperm. Many men with HIV show no material trace of the virus in ...

AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal

... 3 trials which will include approximately 1,500 men with symptomatic BPH in the United States, Canada ... (BPH) is one of the most common diseases of aging men - affecting more than 20 million men in the United States - but its etiology is far ...

When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer

... the first systematic surveillance program of men with prostate cancer to look for biological clues ... of six institutions nationwide will enroll men in a cancer-surveillance study to look for ... or "watchful waiting." For most men with prostate cancer, the disease never ...

FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA

... Prostate cancer is the most common cancer in men in the U.S., excluding skin cancer, and is ... to be diagnosed in 2008 in the U.S.; 28,660 men with prostate cancer are expected to die this year(1). The majority of cases diagnosed are in men over the age of 65. Prostate cancer can be ...

AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan

... convenient and safe treatment for the millions of men with BPH." THE POSTER Introduction and ... 3 trials which will include approximately 1,500 men with symptomatic BPH in the United States, Canada ... (BPH) is one of the most common diseases of aging men - affecting more than 20 ...

AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia

... 3 trials which will include approximately 1,500 men with symptomatic BPH in the United States, Canada ... (BPH) is one of the most common diseases of aging men - affecting more than 20 million men in the United States - but its etiology is far ...

Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded

... to offering new recovery options for the brave men and women who have served our country," Dr. ... the impact of combat injuries on the fine men and women of our Armed Forces," Dr. Cosgrove ... blast injuries and to enable our injured men and women to return to productive lives," Dr. ...

FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE

... as possible to enable us to bring PROVENGE to the men in need of a new treatment option." Conference ... 3 study, which enrolled just over 500 men with metastatic, androgen independent prostate ... common cancer worldwide. More than one million men in the United States have prostate cancer, with ...

Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor

... cause of death in the United States for both men and women. Lifestyle changes, medicines, and/or ... risk. While women are four times more likely than men to develop the disease, men also suffer from osteoporosis. About Skin Care ...

Barr Launches Generic Fosamax(R) Tablets, 70 mg

... women; for the treatment to increase bone mass in men with osteoporosis; for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily ... for the treatment of Paget's disease of bone in men and women. Fosamax Tablets, 70 mg had annual ...

Of mice and men: new male contraceptives successful in rodents and humans

... none of them quite perfect. But what if men want to help out? They have only two options -- ... but get old in long-term relationships. Will men ever have a way to reliably make sure that nobody ... pundits have predicted new contraceptives for men within the next 5 to 10 years. But judging from ...

Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients

... compound in development for the treatment of men with hormone resistant prostate cancer (HRPC), ... these therapies can provide great benefits, most men will become resistant to them. Currently, the ... patients shown to improve survival in men with HRPC is chemotherapy with docetaxel." "The ...

OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer

... positions the availability of OGX-011 treatment to a larger number of men with prostate cancer." The Phase 3 trial has been designed in ... revised trial will be a randomized, controlled, international study in 800 men with metastatic CRPC who are in need of first-line chemotherapy. Patients ...

Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August

... at Amgen. "Likewise, there is currently no approved treatment for the men and women receiving hormone ablation therapy for prostate or breast cancer ... Bone Loss In the U.S., prostate cancer is the most common cancer in men and breast cancer is the most common cancer in women. It is common for ...

Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting

... placebo-controlled, multi-center, phase III trial of sipuleucel-T in men with metastatic, androgen independent prostatic adenocarcinoma (AIPC)." ... (sipuleucel-T), Dendreon's investigational product candidate for men with advanced prostate cancer representing the first in a new class of ...

Dendreon Reports Fourth Quarter and 2008 Year End Financial Results

... active cellular immunotherapy PROVENGE(R) (sipuleucel-T) in men with androgen-independent prostate cancer. While Dendreon remains blinded ... to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the ...

OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009

... in combination with docetaxel as second-line chemotherapy in men with CRPC, via the SPA process. In a letter from the FDA ... in combination with docetaxel as second-line chemotherapy in men with CRPC. OncoGenex has revised the protocol based on the FDA's ...

While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas

... enhancement, to university teaching programs, and even to helping put men on Mars. It also launched--and quickly closed--an outside funding ... of that industry strength than being called upon to help NASA put men on Mars? LMI's software is integral to the space agency's ...

China Sky One Medical, Inc. Receives Scientific Achievement Award

... Dispersible Tablets are intended for the treatment of enlarged prostate in men and can be easily absorbed and digested by the human body. Jin Chuang has ... there is a huge potential market for drugs that treat enlarged prostate in men and we forecast that the sales of Naftopidil Dispersible Tablets will help ...

Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting

... Colorectal cancer is the third most common cancer diagnosed in men and in women in the United States (U.S.). The American Cancer Society ... 2008. Colorectal cancer is the second leading cause of cancer death among men and women in the U.S. and it has been estimated that more than 49,000 ...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

... Development -- Results From NEBIDO Phase III Trial Shows 94 Percent of men Maintained Normal Testosterone Levels Throughout Treatment -- ... for the treatment of male hypogonadism. DELATESTRYL is contraindicated in men with carcinomas of the breast or with known, or suspected, carcinomas of ...
Other Contents
(Date:9/16/2014)... BEACH GARDENS, Fla. , Sept. 16, 2014 ... of biometric identity management solutions, announced today the ... solution designed to authenticate the identity of an ... The Android-based Verifier Sentry rapidly reads credential ... credential holder,s ID by matching the biometric to ...
(Date:9/15/2014)... Human skin and gut microbes influence processes from digestion ... are the most biodiverse terrestrial ecosystems on the planet, ... trees in the tropics. Smithsonian scientists and colleagues working ... samples from a single tree were home to more ... from 57 tree species contained more than 7,000 different ...
(Date:9/15/2014)... mechanical solution to avoid chromosome sorting errors, researchers ... Express. , This natural safeguard prevents ... infertility, miscarriage, or congenital conditions. , "Mistakes ... what exactly goes wrong is often not understood," ... for Cell Biology at the University of Edinburgh ...
Breaking Biology News(10 mins):Cross Match Launches New Identity Management Handheld Solution 2Smithsonian scientists discover tropical tree microbiome in Panama 2Cells simply avoid chromosome confusion 2Cells simply avoid chromosome confusion 3
(Date:9/16/2014)... abnormalities in the adrenergic and noradrenergic systems, both ... play a role in the development of post-traumatic ... no genetic evidence of this connection. A collaborative ... Mailman School of Public Health and the University ... gene and childhood adversity. For individuals with two ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Beginning October 1st ... a new service offering for its clients who book a ... the volume of business they buy. Most recurring visit ... during the work week, but others include clients whose unique ... pet sitter on a daily basis. The newly ...
(Date:9/16/2014)... 16, 2014 The Pain Center ... by Ranking Arizona magazine, has selected Analance ™, ... enterprise. , With TPC seeing hundreds of thousands ... repository that was managed through “home grown” systems trying ... and clinical leadership teams. “Our current tools were ...
(Date:9/16/2014)... 2014 Founded by former Miami Beach ... a political organization fighting to legalize medical marijuana in ... The After Party recently commissioned a shot-for-shot parody video ... from the movie “Grease.” ( http://youtu.be/zdcvhUgeDRg ) , Called ... the musical parody faithfully recreates the carnival scene made ...
(Date:9/16/2014)... 16, 2014 Synergy Research Group has ... gives the best detail and analysis of the state ... a variety of sources, including Ministry of Health in ... will give readers actionable intelligence on clinical trials in ... relied on by the local and international life science ...
Breaking Medicine News(10 mins):Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 2Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 3Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 2Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 3Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3Health News:Miami Beach Politician Drives 1,400 Miles to Texas to Shoot “Grease” Parody Video Supporting the Legalization of Medical Marijuana in Florida 2Health News:Synergy Research Group Debuts Ukraine Orange Paper 2
Other TagsOther Tags